Orphan diseases and orphan drugs:
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Manchester
Manchester Univ. Pr.
1986
|
| Schriftenreihe: | Fulbright papers
3 |
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | X, 228 S. |
| ISBN: | 0719022959 |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV000741640 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 880511s1986 |||| 00||| eng d | ||
| 020 | |a 0719022959 |9 0-7190-2295-9 | ||
| 035 | |a (OCoLC)644379602 | ||
| 035 | |a (DE-599)BVBBV000741640 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 | ||
| 245 | 1 | 0 | |a Orphan diseases and orphan drugs |c ed. by I. Herbert Scheinberg ... |
| 264 | 1 | |a Manchester |b Manchester Univ. Pr. |c 1986 | |
| 300 | |a X, 228 S. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Fulbright papers |v 3 | |
| 650 | 4 | |a Industria farmacéutica | |
| 650 | 0 | 7 | |a Seltene Krankheit |0 (DE-588)4180919-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittel |0 (DE-588)4003115-9 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Chemotherapie |0 (DE-588)4127083-6 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1985 |z Kent |2 gnd-content | |
| 689 | 0 | 0 | |a Seltene Krankheit |0 (DE-588)4180919-1 |D s |
| 689 | 0 | 1 | |a Chemotherapie |0 (DE-588)4127083-6 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Arzneimittel |0 (DE-588)4003115-9 |D s |
| 689 | 1 | 1 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |D s |
| 689 | 1 | |5 DE-604 | |
| 700 | 1 | |a Scheinberg, I. Herbert |e Sonstige |4 oth | |
| 830 | 0 | |a Fulbright papers |v 3 |w (DE-604)BV000020842 |9 3 | |
| 856 | 4 | 2 | |m GBV Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=000464259&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-000464259 | ||
Datensatz im Suchindex
| _version_ | 1804115193605652480 |
|---|---|
| adam_text | ORPHAN DISEASES AND ORPHAN DRUGS / EDITED BY A. HERBERT SCHEINBERG AND].
M. WALSHE MANCHESTER UNIVERSITY PRESS IN ASSOCIATION WITH THE FULBRIGHT
COMMISSION, LONDON CONTENTS FOREWORD PREFACE ACKNOWLEDGEMENTS JOHN E.
FRANKLIN IX XI XII 1 ORPHAN DRUGS: FOOD FOR THOUGHT 2 GENETICS AND
ORPHAN DISEASES 3 THE NATURAL AND UNNATURAL HISTORY OF WILSON S DISEASE
4 THE ADOPTION OF WILSON S DISEASE INTO THE FAMILY OF CURABLE DISEASES 5
THE CHEMISTRY OF TRIENTINE 6 THE METABOLISM OF TRIENTINE: ANIMAL STUDIES
7 THE HISTORY OF PENICILLAMINE 8 THE DEVELOPMENT OF TRIENTINE
DIHYDROCHLORIDE, 1977-85 J. M. WALSHE HARRY HARRIS IRMIN STERNLIEB & I.
HERBERT SCHEINBERG 16 I. HERBERT SCHEINBERG 2O HENRY B. F. DIXON 23 K.
R. GIBBS & J . M . WALSHE 33 MARVIN E. JAFFE 43 ROGER HUMPHREYS & RUPERT
PURCHASE 53 9 THE CONTINUING STORY OF COPPER AND ZINC G. SCHOUWINK 56 10
ZINC SULPHATE: A RATIONAL CHOICE FOR THE TREATMENT OF WILSON S DISEASE
T. U. HOOGENRAAD 62 VI CONTENTS 11 THE COPPER-MOLYBDENUM INTERACTION IN
RUMINANTS: THE INVOLVEMENT OF IAN BREMNER & THIOMOLYBDATES COLINF. MILLS
68 12 TETRATHIOMOLYBDATE (MOS 4 ) AS AN ANTI-COPPER AGENT IN MAN
J.M.WALSHE 76 13 THE ROLE OF DMPS AND OTHER CHELATING AGENTS IN THE
MANAGEMENT OF CHILDHOOD J. JULIAN CHISOLM, JR, & LEAD POISONING
D.J.THOMAS 86 14 THE ETHICS OF EXPERIMENTS WITH HUMAN SUBJECTS G. R.
DUNSTAN 98 15 COLLABORATIVE EFFORTS ON BEHALF OF ORPHAN DISEASES CAROLYN
H. ASBURY 106 16 THE DEVELOPMENT OF ORPHAN DRUGS: AN INDUSTRY
PERSPECTIVE BERT SPILKER 119 17 THE HISTORY AND DEVELOPMENT OF THE
ORPHAN DRUG ACT HON. HENRY A. WAXMAN 135 18 UK REGULATORY REQUIREMENTS
FOR ORPHAN DRUGS R. D. MANN 146 19 ORPHAN DRUG DEVELOPMENT PROGRAMMES: A
JUSTIFIED EXPENDITURE OF RESOURCES GLENNA M. CROOKS 150 20 THE US ORPHAN
DRUG DEVELOPMENT PROGRAMME: INCENTIVES AND RESULTS MARION J. FINKEL 159
21 THE GREAT NEGLECTED DISEASES OF MANKIND, OR, ALL THE WORLD S AN
ORPHANAGE KENNETH S. WARREN 169 22 DRUG DEVELOPMENT AND DELIVERY D. G.
TAYLOR & PROGRAMMES FOR THE THIRD WORLD J. P. GRIFFIN 177 CONTENTS VII
23 FDA EVALUATION OF AN ORPHAN DRUG WILLIAM H. BACHRACH 190 24 THE
DECLINE AND FALL OF THALIDOMIDE D. M. BURLEY 195 25 PENICILLAMINE AND
WILSON S DISEASE REVISITED 1. HERBERT SCHEINBERG 202 ROUND-TABLE
DISCUSSION 204 AFTER-CONGRESS ADDRESSES 216 PARTICIPANTS 221 INDEX 223
|
| any_adam_object | 1 |
| building | Verbundindex |
| bvnumber | BV000741640 |
| ctrlnum | (OCoLC)644379602 (DE-599)BVBBV000741640 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01714nam a2200433 cb4500</leader><controlfield tag="001">BV000741640</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">880511s1986 |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0719022959</subfield><subfield code="9">0-7190-2295-9</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)644379602</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV000741640</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Orphan diseases and orphan drugs</subfield><subfield code="c">ed. by I. Herbert Scheinberg ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Manchester</subfield><subfield code="b">Manchester Univ. Pr.</subfield><subfield code="c">1986</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">X, 228 S.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Fulbright papers</subfield><subfield code="v">3</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Industria farmacéutica</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Seltene Krankheit</subfield><subfield code="0">(DE-588)4180919-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Chemotherapie</subfield><subfield code="0">(DE-588)4127083-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1985</subfield><subfield code="z">Kent</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Seltene Krankheit</subfield><subfield code="0">(DE-588)4180919-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Chemotherapie</subfield><subfield code="0">(DE-588)4127083-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Scheinberg, I. Herbert</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Fulbright papers</subfield><subfield code="v">3</subfield><subfield code="w">(DE-604)BV000020842</subfield><subfield code="9">3</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">GBV Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=000464259&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-000464259</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift 1985 Kent gnd-content |
| genre_facet | Konferenzschrift 1985 Kent |
| id | DE-604.BV000741640 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-09T15:18:43Z |
| institution | BVB |
| isbn | 0719022959 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-000464259 |
| oclc_num | 644379602 |
| open_access_boolean | |
| owner | DE-12 |
| owner_facet | DE-12 |
| physical | X, 228 S. |
| publishDate | 1986 |
| publishDateSearch | 1986 |
| publishDateSort | 1986 |
| publisher | Manchester Univ. Pr. |
| record_format | marc |
| series | Fulbright papers |
| series2 | Fulbright papers |
| spelling | Orphan diseases and orphan drugs ed. by I. Herbert Scheinberg ... Manchester Manchester Univ. Pr. 1986 X, 228 S. txt rdacontent n rdamedia nc rdacarrier Fulbright papers 3 Industria farmacéutica Seltene Krankheit (DE-588)4180919-1 gnd rswk-swf Arzneimittel (DE-588)4003115-9 gnd rswk-swf Arzneimittelentwicklung (DE-588)4143176-5 gnd rswk-swf Chemotherapie (DE-588)4127083-6 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 1985 Kent gnd-content Seltene Krankheit (DE-588)4180919-1 s Chemotherapie (DE-588)4127083-6 s DE-604 Arzneimittel (DE-588)4003115-9 s Arzneimittelentwicklung (DE-588)4143176-5 s Scheinberg, I. Herbert Sonstige oth Fulbright papers 3 (DE-604)BV000020842 3 GBV Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=000464259&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Orphan diseases and orphan drugs Fulbright papers Industria farmacéutica Seltene Krankheit (DE-588)4180919-1 gnd Arzneimittel (DE-588)4003115-9 gnd Arzneimittelentwicklung (DE-588)4143176-5 gnd Chemotherapie (DE-588)4127083-6 gnd |
| subject_GND | (DE-588)4180919-1 (DE-588)4003115-9 (DE-588)4143176-5 (DE-588)4127083-6 (DE-588)1071861417 |
| title | Orphan diseases and orphan drugs |
| title_auth | Orphan diseases and orphan drugs |
| title_exact_search | Orphan diseases and orphan drugs |
| title_full | Orphan diseases and orphan drugs ed. by I. Herbert Scheinberg ... |
| title_fullStr | Orphan diseases and orphan drugs ed. by I. Herbert Scheinberg ... |
| title_full_unstemmed | Orphan diseases and orphan drugs ed. by I. Herbert Scheinberg ... |
| title_short | Orphan diseases and orphan drugs |
| title_sort | orphan diseases and orphan drugs |
| topic | Industria farmacéutica Seltene Krankheit (DE-588)4180919-1 gnd Arzneimittel (DE-588)4003115-9 gnd Arzneimittelentwicklung (DE-588)4143176-5 gnd Chemotherapie (DE-588)4127083-6 gnd |
| topic_facet | Industria farmacéutica Seltene Krankheit Arzneimittel Arzneimittelentwicklung Chemotherapie Konferenzschrift 1985 Kent |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=000464259&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| volume_link | (DE-604)BV000020842 |
| work_keys_str_mv | AT scheinbergiherbert orphandiseasesandorphandrugs |